Petit, ClaireClairePetitLee, AnneAnneLeeMa, JunJunMaLacas, BenjaminBenjaminLacasNg, Wai TongWai TongNgChan, Anthony T CAnthony T CChanRUEY-LONG HONGChen, Ming-YuanMing-YuanChenChen, LeiLeiChenLi, Wen-FeiWen-FeiLiHuang, Pei-YuPei-YuHuangTan, TerenceTerenceTanNgan, Roger K CRoger K CNganZhu, GuopeiGuopeiZhuMai, Hai-QiangHai-QiangMaiHui, Edwin PEdwin PHuiFountzilas, GeorgeGeorgeFountzilasZhang, LiLiZhangCarmel, AlexandraAlexandraCarmelKwong, Dora L WDora L WKwongMoon, JamesJamesMoonBourhis, JeanJeanBourhisAuperin, AnneAnneAuperinPignon, Jean-PierreJean-PierrePignonBlanchard, PierrePierreBlanchard2023-07-142023-07-142023-0614702045https://scholars.lib.ntu.edu.tw/handle/123456789/633597The meta-analysis of chemotherapy for nasopharynx carcinoma (MAC-NPC) collaborative group previously showed that the addition of adjuvant chemotherapy to concomitant chemoradiotherapy had the highest survival benefit of the studied treatment regimens in nasopharyngeal carcinoma. Due to the publication of new trials on induction chemotherapy, we updated the network meta-analysis.en[SDGs]SDG3journal article10.1016/S1470-2045(23)00163-8372698422-s2.0-85160886678https://api.elsevier.com/content/abstract/scopus_id/85160886678